Certis Biologicals
Kasia O'Donnell is a Regulatory Affairs Associate at Certis USA since January 2019, where responsibilities include managing compliance and regulatory requirements. Additionally, Kasia has experience as an HR Generalist at Certis USA and previously worked as an HR/QA Representative at Nave Communications from September 2016 to October 2018. Kasia also contributed to the National Institute on Aging as an ACUC Member from March 2015 to October 2016. Educational qualifications include a Master's degree in Industrial Engineering from Wroclaw University of Economics and a Master of Engineering (MEng) in Industrial Engineering and HR Management from Wroclaw University of Economics and Business, completed between 1998 and 2003.
Certis Biologicals
Certis Biologicals is a pioneer in the development of biological pesticides and has become one of the world’s leading manufacturers and distributors of biopesticides. We specialize in: Biological product development, from screening to formulation to field development Manufacturing: fermentation and formulation Global registrations for biological products Global sales channels. We export to more than 30 countries. Certis Biologicals traces its roots to some of the early leaders in the development of biological and botanical pesticides, beginning with the formation of Thermo Trilogy in 1996 and the acquisition of Neem Technologies from W.R. Grace. Since then, the company has grown by identifying and acquiring products that complement its product line. These include baculovirus products acquired from Biosys in 1997 and Bt bioinsecticide products acquired from Novartis in 1997 and Ecogen in 2002. In 2001, Mitsui & Co., a leading Japanese trading company, acquired Thermo Trilogy and renamed it Certis U.S.A. L.L.C. Within Mitsui's AgriScience Division, Certis Biologicals is positioned as the global competence center for biological control technologies. Today the company’s product line represents some of finest bioproducts and active ingredients in the industry.